About Cogstate
Cogstate is a company based in New Haven (United States) founded in 1999. Cogstate offers products and services including Digital Cognitive Assessment, Endpoint Data Quality, Remote Assessment, Scientific Consulting, and Healthcare Cognitive Screening. Cogstate operates in a competitive market with competitors including BrainCheck, Thymia, Cognivue, NEUROPHET and Altoida, among others.
- Headquarter New Haven, United States
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cogstate Ltd
-
Annual Revenue
$53.53 M (USD)23.7as on Jun 30, 2025
-
Net Profit
$10.23 M (USD)88.35as on Jun 30, 2025
-
EBITDA
$16.24 M (USD)82.84as on Jun 30, 2025
-
Latest Funding Round
$2 M (USD), Post-IPO
May 12, 2015
-
Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cogstate
Cogstate is a publicly listed company on the ASX with ticker symbol CGS in Australia, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Cogstate
Cogstate offers a comprehensive portfolio of products and services, including Digital Cognitive Assessment, Endpoint Data Quality, Remote Assessment, Scientific Consulting, and Healthcare Cognitive Screening.
Provides valid measures of cognition for clinical trials
Ensures consistent administration in research settings
Supports direct-to-patient evaluations remotely
Offers expertise for cognitive health studies
Helps monitor cognition in clinical care
People of Cogstate
Unlock access to complete
Funding Insights of Cogstate
Investors in Cogstate
Cogstate has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Dagmar Dolby.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
DD
Dagmar Dolby |
-
|
Locked | Locked | Locked |
Investor details for Cogstate
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cogstate
Investment portfolio details for Cogstate
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cogstate
Detailed financials for Cogstate
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cogstate Comparisons
Peer comparison for Cogstate
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cogstate
Cogstate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BrainCheck, Thymia, Cognivue, NEUROPHET and Altoida, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cognitive health is tracked via mobile interactive games.
|
|
| Locked | Locked | Locked |
AI-based video games are developed for mental health assessments.
|
|
| Locked | Locked | Locked |
Offering embedded vision processing solutions
|
|
| Locked | Locked | Locked |
AI-based simulation software for electrical brain stimulation is developed.
|
|
| Locked | Locked | Locked |
Provider of a AI-based app which can predict the onset of Alzheimer's
|
|
| Locked | Locked | Locked |
A wearable device for brain analysis and assessment is provided.
|
Detailed competitors of Cogstate
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cogstate
Complete news archive for Cogstate
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cogstate
Cogstate was founded in 1999 and raised its 1st funding round 14 years after it was founded.
Cogstate is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
Annual revenue of Cogstate is $53.53M as on Jun 30, 2025.
Cogstate offers cognitive science solutions focused on optimizing the measurement of cognition to guide better decision-making for clinical trials, academic research, healthcare and brain injury. For clinical trials it offers consulting services, precision recruitment services, study design, assessment, tests and analysis solutions. It offers computerized cognitive assessment to detect even subtle change that could signify the early stages of dementia, or to monitor change in cognitive function following concussion or drug treatment. It also offers concussion test and management system which assists medical providers in measuring the cognitive function of athletes after suspected concussions or Traumatic Brain Injuries (TBI).
Cogstate's top competitors include BrainCheck, NEUROPHET and Altoida.
Cogstate offers Digital Cognitive Assessment, Endpoint Data Quality, Remote Assessment, Scientific Consulting, and Healthcare Cognitive Screening.
Yes, Cogstate is publicly traded on ASX under the ticker symbol CGS.
Cogstate has 1 investor. Key investors include Dagmar Dolby.
The ticker symbol of Cogstate is CGS on ASX.